Publicaciones en colaboración con investigadoras/es de University of Paris-Sorbonne (22)

2024

  1. 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 6, pp. 752-759

2023

  1. Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

    Arthritis and Rheumatology, Vol. 75, Núm. 5, pp. 816-825

  2. Mechanisms and rationale for uricase use in patients with gout

    Nature Reviews Rheumatology, Vol. 19, Núm. 10, pp. 640-649

  3. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 10, pp. 1248-1257

2022

  1. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

    Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658

2021

  1. Serum uric acid and mortality thresholds among men and women in the Irish health system: A cohort study

    European Journal of Internal Medicine, Vol. 84, pp. 46-55

2019

  1. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600

2018

  1. International position paper on the appropriate use of uricosurics with the introduction of lesinurad

    Clinical Rheumatology, Vol. 37, Núm. 12, pp. 3159-3165

2017

  1. 2016 updated EULAR evidence-based recommendations for the management of gout

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 29-42

  2. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 429-438

2016

  1. Computational Lexical Analysis of the Language Commonly Used to Describe Gout

    Arthritis Care and Research, Vol. 68, Núm. 6, pp. 763-768

  2. Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated

    Journal of Rheumatology, Vol. 43, Núm. 1, pp. 150-153

  3. Performance of classification criteria for gout in early and established disease

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 178-182

  4. Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard

    Arthritis Care and Research, Vol. 68, Núm. 12, pp. 1894-1898

2015

  1. Serumuric acidandthe riskof cardiovascular and renal disease

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1729-1741

  2. Study for updated gout classification criteria: Identification of features to classify gout

    Arthritis Care and Research, Vol. 67, Núm. 9, pp. 1304-1315

2013

  1. Serum uric acid and metabolic risk

    Current Medical Research and Opinion, Vol. 29, Núm. SUPPL.3, pp. 9-15

2012

  1. 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1431-1446

  2. 2012 American college of rheumatology guidelines for management of gout. part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1447-1461

2011

  1. EULAR recommendations for calcium pyrophosphate deposition. Part II: Management

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 571-575